32 results
S-1
EX-4
LSTA
Lisata Therapeutics Inc
16 Oct 00
IPO registration
12:00am
only and do not constitute substantive
matters to be considered in construing the terms and provisions of this
Agreement.
24. Gender … and Number. Words of any gender used in this Agreement shall
be held and construed to include any other gender, and words in the singular
number shall
S-1
EX-4
LSTA
Lisata Therapeutics Inc
16 Oct 00
IPO registration
12:00am
.
25. Gender and Number. Words of any gender used in this Agreement shall
be held and construed to include any other gender, and words
8-K
EX-10.4
LSTA
Lisata Therapeutics Inc
24 Jan 11
Completion of Acquisition or Disposition of Assets
12:00am
: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neutral genders; the feminine gender shall … include the masculine and neutral genders; and the neutral gender shall include masculine and feminine genders.
(b) The parties hereto agree that any
8-K
EX-10.1
LSTA
Lisata Therapeutics Inc
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neutral … genders; the feminine gender shall include the masculine and neutral genders; and the neutral gender shall include masculine and feminine genders.
(b
8-K
EX-2.2
8rngs
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.3
641o6m
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-10.2
zeo 3cxff1
16 Sep 04
Unregistered Sales of Equity Securities
12:00am
8-K
EX-10.2
1lv13opv8bix0w3
29 Sep 14
NeoStem Secures Debt Facility
12:00am
8-K
EX-10.4
h87bjg4017pe8uk8jhv
13 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
8rziuv39yc
19 Nov 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
cz135xi9
23 Sep 10
NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement
12:00am
425
EX-2.1
gs5ztml fmu2sl1
23 Sep 10
Business combination disclosure
12:00am
425
EX-2.1
c91 4tn5163j3s1bnn6
14 Jul 11
Business combination disclosure
12:00am